Geron Corp (NASDAQ:GERN)

CAPS Rating: 3 out of 5

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

Recs

0
Player Avatar pick1998 (90.43) Submitted: 1/25/2009 2:16:16 AM : Underperform Start Price: $7.47 GERN Score: +10.59

over hyped for stem cell curing power and telemorase potential. High valuation, but early clinical development. High cash burn, which is dangerous in 2009 or so.

Report this Post 1 Comment
Member Avatar elwalvador (< 20) Submitted: 2/3/2009 4:53:23 PM
Recs: 0

I went long at $8.17. I made a video of it too, since it's my first trade ever and put it on youtube. I will be posting all of my trades in my video "trading diary". youtube vid is called "long GERN $8.17" http://www.youtube.com/watch?v=RjqbfzGvSS4

Report this Post

Featured Broker Partners


Advertisement